Is Lions Mane Cognition Randomized Trial safe?

Updated June 2026

Quick Answer

Lions Mane Cognition Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Magnitude, Risk Factors, and Factors Associated With Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-analysis.

Key Takeaways

  • 01Magnitude, Risk Factors, and Factors Associated With Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-analysis. [World Molecular Imaging Congress 2022 (2023)]
  • 02Similarly, the specific binding of [C]mG2P001 was also increased with more unlabeled mG2P001 in the incubation media. [World Molecular Imaging Congress 2022 (2023)]
  • 03[18F]FSPG, a glutamate analogue containing an [18F]fluoropropyl group, is used to image expression of the cystine/glutamate (x) transporter, which is upregulated in a variety of tumors, including non-small cell lung cancer, breast cancer, and liver cancer and has been associated with poor outcomes (). [World Molecular Imaging Congress 2022 (2023)]
  • 04Title: World Molecular Imaging Congress 2022 Date: September 28-October 1, 2022 Location: Miami, FL, USA Sponsorship: Publication of this supplement was sponsored by the World Molecular Imaging Society. [World Molecular Imaging Congress 2022 (2023)]
The current Migaku evidence database contains 2 reusable source documents for Lions Mane Cognition Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Magnitude, Risk Factors, and Factors Associated With Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-analysis. [World Molecular Imaging Congress 2022 (2023); evidence level 4] - Similarly, the specific binding of [C]mG2P001 was also increased with more unlabeled mG2P001 in the incubation media. [World Molecular Imaging Congress 2022 (2023); evidence level 4] - [18F]FSPG, a glutamate analogue containing an [18F]fluoropropyl group, is used to image expression of the cystine/glutamate (x) transporter, which is upregulated in a variety of tumors, including non-small cell lung cancer, breast cancer, and liver cancer and has been associated with poor outcomes (). [World Molecular Imaging Congress 2022 (2023); evidence level 4] - Title: World Molecular Imaging Congress 2022 Date: September 28-October 1, 2022 Location: Miami, FL, USA Sponsorship: Publication of this supplement was sponsored by the World Molecular Imaging Society. [World Molecular Imaging Congress 2022 (2023); evidence level 4] - 53 <sup>rd</sup> EASD Annual Meeting of the European Association for the Study of Diabetes : Lisbon, Portugal, 11 - 15 September 2017. [53 &lt;sup&gt;rd&lt;/sup&gt; EASD Annual Meeting of the European Association for the Study of Diabetes : Lisbon, Portugal, 11 - 15 September 2017. (2017); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. World Molecular Imaging Congress 2022
  2. 53 &lt;sup&gt;rd&lt;/sup&gt; EASD Annual Meeting of the European Association for the Study of Diabetes : Lisbon, Portugal, 11 - 15 September 2017.